SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-002576
Filing Date
2020-02-14
Accepted
2020-02-14 17:21:59
Documents
58
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1191644
2 ex31-1.htm EX-31.1 14830
3 ex31-2.htm EX-31.2 13811
4 ex32-1.htm EX-32.1 8798
5 ex32-2.htm EX-32.2 7792
  Complete submission text file 0001493152-20-002576.txt   5609397

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ppcb-20191231.xml EX-101.INS 824823
7 XBRL SCHEMA FILE ppcb-20191231.xsd EX-101.SCH 59565
8 XBRL CALCULATION FILE ppcb-20191231_cal.xml EX-101.CAL 53669
9 XBRL DEFINITION FILE ppcb-20191231_def.xml EX-101.DEF 255813
10 XBRL LABEL FILE ppcb-20191231_lab.xml EX-101.LAB 414441
11 XBRL PRESENTATION FILE ppcb-20191231_pre.xml EX-101.PRE 324213
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 20622019
SIC: 2834 Pharmaceutical Preparations